A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma | Zendy

Aliihsan Gemici | Zendy; Hülya Bilgen | Zendy; Cem Erdoğan | Zendy; Abdullah Kansu | Zendy; Oktay Olmuşçelik | Zendy; Hüseyin Saffet Beköz | Zendy; Rümeysa Çakmak | Zendy; Ali Mert | Zendy; Ömür Gökmen Sevindik | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma

Author(s) -

Aliihsan Gemici,

Hülya Bilgen,

Cem Erdoğan,

Abdullah Kansu,

Oktay Olmuşçelik,

Hüseyin Saffet Beköz,

Rümeysa Çakmak,

Ali Mert,

Ömür Gökmen Sevindik

Publication year - 2020

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-2009-77

Subject(s) - medicine , covid-19 , mechanical ventilation , demographics , single center , cohort , guideline , retrospective cohort study , pathology , demography , disease , sociology , infectious disease (medical specialty)

A SARS-Cov2 infection which was first arised from Wuhan in December 2019 and named as COVID-19. Still there lacks either a specific treatment or a vaccine to treat COVID-19. Convalescent plasma (CP) was previously used successfully to treat SARS-CoV-1 and MERS infections. Health authority in Turkey has published a guideline to integrate this promising option in the treatment process of patients who are prone to high risk of developing severe COVID 19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research